Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors

Go back to Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors
(NASDAQ: XAIR) Delayed: 0.38 +0.02 (5.56%)
Previous Close $0.36    52 Week High
Open $0.36    52 Week Low
Day High $0.39    P/E N/A 
Day Low $0.37    EPS
Volume 204,624